stockportfolio.pro
Stocks / OGN vs WAY
OGN vs WAY
Organon & Co. and Waystar Holding Corp. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Organon & Co. (OGN) | Waystar Holding Corp. (WAY) | |
|---|---|---|
| Market cap | $3.5B | $3.6B |
| Revenue (latest FY) | $6.22B | $1.10B |
| Net income (latest FY) | $187.00M | $112.09M |
| Revenue growth (5y CAGR) | -1.0% | 16.0% |
| Net margin | 3.0% | 10.2% |
| Return on equity | 24.9% | 2.9% |
| P/E ratio | 14.4 | 28.0 |
| Dividend yield | 0.6% | — |
| Profitable years (of last 10) | 7 | 1 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open OGN — free Open WAY — freeFrequently asked questions
Which is bigger, OGN or WAY?
Waystar Holding Corp. is larger by market capitalization — $3.6B versus $3.5B.
Which grows faster, OGN or WAY?
Over the last five fiscal years, Waystar Holding Corp. grew revenue faster — 16.0%/yr versus -1.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.